Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |